Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • Log in

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • Log in
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

Table of Contents

January 1, 1985; Volume 134,Issue 1
  • You have accessRestricted access
    Immunoglobulin subclass (IgG3) restriction of anti-P and anti-Pk antibodies in patients of the rare p blood group.
    T Söderström, A Enskog, B E Samuelsson and B Cedergren
    J Immunol January 1, 1985, 134 (1) 1-3;
  • You have accessRestricted access
    Splenic B cells from CBA/N mice acquire responsiveness to anti-immunoglobulin after a brief treatment with pronase.
    M Ramanadham, S V Gollapudi and M Kern
    J Immunol January 1, 1985, 134 (1) 4-6;
  • You have accessRestricted access
    Induction of IA antigens in murine renal transplants.
    E M Benson, R B Colvin and P S Russell
    J Immunol January 1, 1985, 134 (1) 7-9;
  • You have accessRestricted access
    Syngeneic responses by murine thymocytes: a role for non-MHC and non-MLS genes.
    S Wu and D W Thomas
    J Immunol January 1, 1985, 134 (1) 10-15;
  • You have accessRestricted access
    Regulation of T15 idiotype dominance. II. Genes unlinked to the Igh locus regulate T15 dominance of the secondary adoptive transfer response to phosphocholine.
    L S Wicker, G Guelde, I Scher and J J Kenny
    J Immunol January 1, 1985, 134 (1) 16-22;
  • You have accessRestricted access
    Differences in T15 expression of primary and secondary anti-PC responses with T cells from T15+ and T15- donors.
    S K Smyk, M K McNamara, K S Gleason and H Kohler
    J Immunol January 1, 1985, 134 (1) 23-28;
  • You have accessRestricted access
    T cell subsets regulating antibody responses to L-glutamic acid60-L-alanine30-L-tyrosine10 (GAT) in virgin and immunized nonresponder mice.
    C W Pierce, C M Sorensen and J A Kapp
    J Immunol January 1, 1985, 134 (1) 29-36;
  • You have accessRestricted access
    Murine anti-swine T4 and T8 monoclonal antibodies: distribution and effects on proliferative and cytotoxic T cells.
    M D Pescovitz, J K Lunney and D H Sachs
    J Immunol January 1, 1985, 134 (1) 37-44;
  • You have accessRestricted access
    Suppression of in vitro CML generation by alloactivated lymphocytes: analysis of antigen-nonspecific suppressive mechanisms.
    C G Orosz and R M Ferguson
    J Immunol January 1, 1985, 134 (1) 45-50;
  • You have accessRestricted access
    Human C3a-mediated suppression of the immune response. I. Suppression of murine in vitro antibody responses occurs through the generation of nonspecific Lyt-2+ suppressor T cell.
    E L Morgan, M L Thoman, W O Weigle and T E Hugli
    J Immunol January 1, 1985, 134 (1) 51-57;
  • You have accessRestricted access
    A large subpopulation of lymphocytes with T helper phenotype (Leu-3/T4+) exhibits the property of binding to NK cell targets and granular lymphocyte morphology.
    A Velardi, C E Grossi and M D Cooper
    J Immunol January 1, 1985, 134 (1) 58-64;
  • You have accessRestricted access
    Natural killer cell-mediated cytotoxicity does not depend on recognition of mannose 6-phosphate residues.
    H D Haubeck, E Kölsch, M Imort, A Hasilik and K von Figura
    J Immunol January 1, 1985, 134 (1) 65-69;
  • You have accessRestricted access
    Blocking of CTL-mediated killing by monoclonal antibodies to LFA-1 and Lyt-2, 3. II. Evidence that trypsin pretreatment of target cells removes a non-H-2 molecule important in killing.
    S H Gromkowski, W Heagy and E Martz
    J Immunol January 1, 1985, 134 (1) 70-77;
  • You have accessRestricted access
    Antiprotozoan activity of nonspecific cytotoxic cells (NCC) from the channel catfish (Ictalurus punctatus).
    S S Graves, D L Evans and D L Dawe
    J Immunol January 1, 1985, 134 (1) 78-85;
  • You have accessRestricted access
    Monoclonal helper T cells induce B cell responses to T-independent antigens: antigen-specific T cells are directly stimulated by activated B cells in the absence of antigen.
    R H DeKruyff, C Clayberger and H Cantor
    J Immunol January 1, 1985, 134 (1) 86-90;
  • You have accessRestricted access
    Dissociation of inductive from differentiative signals transmitted by C8-substituted guanine ribonucleosides to B cells from SJL mice.
    M G Goodman and W O Weigle
    J Immunol January 1, 1985, 134 (1) 91-94;
  • You have accessRestricted access
    Development and distribution of B lineage cells in the domestic cat: analysis with monoclonal antibodies to cat mu-, gamma-, kappa-, and lambda-chains and heterologous anti-alpha antibodies.
    F W Klotz, W E Gathings and M D Cooper
    J Immunol January 1, 1985, 134 (1) 95-100;
  • You have accessRestricted access
    B cell activation. VI. Effects of exogenous diglyceride and modulators of phospholipid metabolism suggest a central role for diacylglycerol generation in transmembrane signaling by mIg.
    K M Coggeshall and J C Cambier
    J Immunol January 1, 1985, 134 (1) 101-107;
  • You have accessRestricted access
    T-T cell interaction in the induction of delayed-type hypersensitivity (DTH) responses: vaccinia virus-reactive helper T cell activity involved in enhanced in vivo induction of DTH responses and its application to augmentation of tumor-specific DTH responses.
    Y Takai, A Kosugi, T Yoshioka, S Tomita, H Fujiwara and T Hamaoka
    J Immunol January 1, 1985, 134 (1) 108-113;
  • You have accessRestricted access
    Immunoregulatory pathways in adult responder mice. II. Regulation of delayed-type hypersensitivity responses by GAT-specific suppressor factors present in GAT-tolerant adult responder mice.
    M K Jenkins, C Waltenbaugh and S D Miller
    J Immunol January 1, 1985, 134 (1) 114-121;
  • You have accessRestricted access
    Analysis of the mode of antigen presentation required for triggering of T cell proliferation by using various azobenzenearsonate-tyrosine derivatives.
    T Tadakuma, T Yasuda, A Tamura, S Saito, T Tsumita and K Saito
    J Immunol January 1, 1985, 134 (1) 122-128;
  • You have accessRestricted access
    Effects of ultraviolet radiation on human epidermal cell alloantigen presentation: initial depression of Langerhans cell-dependent function is followed by the appearance of T6- Dr+ cells that enhance epidermal alloantigen presentation.
    K D Cooper, P Fox, G Neises and S I Katz
    J Immunol January 1, 1985, 134 (1) 129-137;
  • You have accessRestricted access
    Membrane vesicles shed by murine melanoma cells selectively inhibit the expression of Ia antigen by macrophages.
    D D Poutsiaka, E W Schroder, D D Taylor, E M Levy and P H Black
    J Immunol January 1, 1985, 134 (1) 138-144;
  • You have accessRestricted access
    Inhibition of recombinant interferon-gamma-induced Ia antigen expression by shed B16 F10 melanoma cell membrane vesicles.
    D D Poutsiaka, D D Taylor, E M Levy and P H Black
    J Immunol January 1, 1985, 134 (1) 145-150;
  • You have accessRestricted access
    Defective in vitro T cell colony formation in the acquired immunodeficiency syndrome.
    A Winkelstein, R S Klein, T L Evans, B W Dixon, W L Holder and L D Weaver
    J Immunol January 1, 1985, 134 (1) 151-156;
  • You have accessRestricted access
    In vivo administration of purified human interleukin 2. I. Half-life and immunologic effects of the Jurkat cell line-derived interleukin 2.
    M T Lotze, L W Frana, S O Sharrow, R J Robb and S A Rosenberg
    J Immunol January 1, 1985, 134 (1) 157-166;
  • You have accessRestricted access
    Defective IFN-gamma production in the human neonate. I. Dysregulation rather than intrinsic abnormality.
    N Wakasugi and J L Virelizier
    J Immunol January 1, 1985, 134 (1) 167-171;
  • You have accessRestricted access
    Defective IFN-gamma production in the human neonate. II. Role of increased sensitivity to the suppressive effects of prostaglandin E.
    N Wakasugi, J L Virelizier, F Arenzana-Seisdedos, B Rothhut, J M Huerta, F Russo-Marie and W Fiers
    J Immunol January 1, 1985, 134 (1) 172-176;
  • You have accessRestricted access
    Potential Z-DNA-forming elements in serum DNA from human systemic lupus erythematosus.
    P D Van Helden
    J Immunol January 1, 1985, 134 (1) 177-179;
  • You have accessRestricted access
    Hybridoma anti-DNA autoantibodies from patients with rheumatoid arthritis and systemic lupus erythematosus demonstrate similar nucleic acid binding characteristics.
    J Rauch, H Massicotte and H Tannenbaum
    J Immunol January 1, 1985, 134 (1) 180-186;
  • You have accessRestricted access
    Characterization of T lymphocyte subpopulations responsible for deficient interleukin 2 activity in patients with systemic lupus erythematosus.
    Y Murakawa, S Takada, Y Ueda, N Suzuki, T Hoshino and T Sakane
    J Immunol January 1, 1985, 134 (1) 187-195;
  • You have accessRestricted access
    Subsets of Lyt-2+ cells defined by differential expression of the 9F3 antigen: alterations in mice of the lpr/lpr genotype.
    F J Dumont, R C Habbersett and L Z Coker
    J Immunol January 1, 1985, 134 (1) 196-203;
  • You have accessRestricted access
    Effects of short-term administration of sex hormones on normal and autoimmune mice.
    S Ansar Ahmed, M J Dauphinee and N Talal
    J Immunol January 1, 1985, 134 (1) 204-210;
  • You have accessRestricted access
    Human immune responses to synthetic peptides from the Epstein-Barr nuclear antigen.
    G Rhodes, D A Carson, J Valbracht, R Houghten and J H Vaughan
    J Immunol January 1, 1985, 134 (1) 211-216;
  • You have accessRestricted access
    Circadian and/or circahemidian rhythms in nine lymphocyte-related variables from peripheral blood of healthy subjects.
    F A Levi, C Canon, J P Blum, M Mechkouri, A Reinberg and G Mathe
    J Immunol January 1, 1985, 134 (1) 217-222;
  • You have accessRestricted access
    Regulation of antibody responses by rheumatoid factor. I. Polyclonal activation of human B cells by rheumatoid factor-containing preparations from seropositive plasma.
    M V Hobbs, E L Morgan, N L Baker and W O Weigle
    J Immunol January 1, 1985, 134 (1) 223-229;
  • You have accessRestricted access
    Inhibition of human cytotoxic T lymphocyte activity in vitro by autologous peripheral blood granulocytes.
    H T Petrie, L W Klassen and H D Kay
    J Immunol January 1, 1985, 134 (1) 230-234;
  • You have accessRestricted access
    Immunoregulatory T cell circuits in man. Identification of a distinct T cell subpopulation of the helper/inducer lineage that amplifies the development of alloantigen-specific suppressor T cells.
    N K Damle, N Mohagheghpour, G S Kansas, D M Fishwild and E G Engleman
    J Immunol January 1, 1985, 134 (1) 235-243;
  • You have accessRestricted access
    Functional distinctions between the LFA-1, LFA-2, and LFA-3 membrane proteins on human CTL are revealed with trypsin-pretreated target cells.
    S H Gromkowski, A M Krensky, E Martz and S J Burakoff
    J Immunol January 1, 1985, 134 (1) 244-249;
  • You have accessRestricted access
    The human thymic microenvironment. Phenotypic characterization of Hassall's bodies with the use of monoclonal antibodies.
    D F Lobach, R M Scearce and B F Haynes
    J Immunol January 1, 1985, 134 (1) 250-257;
  • You have accessRestricted access
    Characterization of in vivo-activated allospecific T lymphocytes propagated from human renal allograft biopsies undergoing rejection.
    T G Mayer, A A Fuller, T C Fuller, A I Lazarovits, L A Boyle and J T Kurnick
    J Immunol January 1, 1985, 134 (1) 258-264;
  • You have accessRestricted access
    OKT3 monoclonal antibody induces production of colony-stimulating factor(s) for granulocytes and macrophages in cultures of human T lymphocytes and adherent cells.
    E Platzer, B Y Rubin, L Lu, K Welte, H E Broxmeyer and M A Moore
    J Immunol January 1, 1985, 134 (1) 265-271;
  • You have accessRestricted access
    Suppression of human NK cell cytotoxicity by an MLC-Generated cell population.
    P J D'Amore and S H Golub
    J Immunol January 1, 1985, 134 (1) 272-279;
  • You have accessRestricted access
    Cytofluorometric isolation of I937, an Ia antigen-bearing variant of the Ia-negative human monocytic cell line U937.
    B D Gitter, O J Finn and R S Metzgar
    J Immunol January 1, 1985, 134 (1) 280-283;
  • You have accessRestricted access
    Characterization of mononuclear phagocyte subpopulations in the human lung by using monoclonal antibodies: changes in alveolar macrophage phenotype associated with pulmonary sarcoidosis.
    A J Hance, S Douches, R J Winchester, V J Ferrans and R G Crystal
    J Immunol January 1, 1985, 134 (1) 284-292;
  • You have accessRestricted access
    Biochemical models of gamma-interferon action: altered expression of transferrin receptors on murine peritoneal macrophages after treatment in vitro with PMA or A23187.
    J E Weiel, D O Adams and T A Hamilton
    J Immunol January 1, 1985, 134 (1) 293-298;
  • You have accessRestricted access
    Stimulation of in vitro immunoglobulin production by interferon-alpha.
    R H Neubauer, L Goldstein, H Rabin and N Stebbing
    J Immunol January 1, 1985, 134 (1) 299-304;
  • You have accessRestricted access
    MIF-like activity of natural and recombinant human interferon-gamma and their neutralization by monoclonal antibody.
    G B Thurman, I A Braude, P W Gray, R K Oldham and H C Stevenson
    J Immunol January 1, 1985, 134 (1) 305-309;
  • You have accessRestricted access
    Human alloreactive CTL clones: loss and reacquisition of specific cytolytic activity can be regulated by "recombinant" interleukin 2.
    S L Wee, A C Ochoa and F H Bach
    J Immunol January 1, 1985, 134 (1) 310-313;
  • You have accessRestricted access
    Effect of wheat germ agglutinin on the interleukin pathway of human T lymphocyte activation.
    J C Reed, R J Robb, W C Greene and P C Nowell
    J Immunol January 1, 1985, 134 (1) 314-323;
  • You have accessRestricted access
    Reversal of phorbol ester-mediated reduction of cloned T lymphocyte cytolysis by interleukin 2.
    C G Orosz, J W Scott, S Gillis and J H Finke
    J Immunol January 1, 1985, 134 (1) 324-329;
  • You have accessRestricted access
    Activation of human thymocytes via the 50KD T11 sheep erythrocyte binding protein induces the expression of interleukin 2 receptors on both T3+ and T3- populations.
    D A Fox, R E Hussey, K A Fitzgerald, A Bensussan, J F Daley, S F Schlossman and E L Reinherz
    J Immunol January 1, 1985, 134 (1) 330-335;
  • You have accessRestricted access
    Reconstitution of nude mouse T cell function in vivo: IL 2-independent effect of human T cells.
    H M Dosch, D White and C Grant
    J Immunol January 1, 1985, 134 (1) 336-342;
  • You have accessRestricted access
    Studies on the synthesis and secretion of interleukin 1. I. A 33,000 molecular weight precursor for interleukin 1.
    J G Giri, P T Lomedico and S B Mizel
    J Immunol January 1, 1985, 134 (1) 343-349;
  • You have accessRestricted access
    Interleukin 1 production by the human monocyte cell line U937 requires a lymphokine induction signal distinct from interleukin 2 or interferons.
    E P Amento, J T Kurnick and S M Krane
    J Immunol January 1, 1985, 134 (1) 350-357;
  • You have accessRestricted access
    Role of interleukin 1 in experimental pulmonary granuloma in mice.
    K Kobayashi, C Allred, S Cohen and T Yoshida
    J Immunol January 1, 1985, 134 (1) 358-364;
  • You have accessRestricted access
    Strain dependence of muramyl dipeptide-induced LAF(IL 1) release by murine-adherent peritoneal cells.
    O Abehsira-Amar, C Damais, M Parant and L Chedid
    J Immunol January 1, 1985, 134 (1) 365-368;
  • You have accessRestricted access
    T cell-derived B cell growth factor(s) can induce stimulation of both resting and activated B cells.
    C B Thompson, M E Schaefer, F D Finkelman, I Scher, J Farrar and J J Mond
    J Immunol January 1, 1985, 134 (1) 369-374;
  • You have accessRestricted access
    Identification and characterization of a B cell growth inhibitory factor (BIF) on BCGF-dependent B cell proliferation.
    M Kawano, K Iwato and A Kuramoto
    J Immunol January 1, 1985, 134 (1) 375-381;
  • You have accessRestricted access
    Purification and physicochemical characterization of murine T cell replacing factor (TRF).
    K Takatsu, N Harada, Y Hara, Y Takahama, G Yamada, K Dobashi and T Hamaoka
    J Immunol January 1, 1985, 134 (1) 382-389;
  • You have accessRestricted access
    A "lymphokine-like" soluble product that induces proliferation and maturation of B cells appears in the serum-free supernatant of a T cell hybridoma as a consequence of mycoplasmal contamination.
    J J Proust, M A Buchholz and A A Nordin
    J Immunol January 1, 1985, 134 (1) 390-396;
  • You have accessRestricted access
    Lymphokine-mediated induction of cytolytic activity in a T cell hybridoma.
    O Kanagawa and J M Chiller
    J Immunol January 1, 1985, 134 (1) 397-403;
  • You have accessRestricted access
    Suppressor T lymphocyte induction by a factor released from cultured blastocysts.
    T Mayumi, S Bitoh, S Anan, T Hama, S Fujimoto and H Yamamoto
    J Immunol January 1, 1985, 134 (1) 404-409;
  • You have accessRestricted access
    Comparative structural analysis of HLA-A3 antigens distinguishable by cytotoxic T lymphocytes: variant E1.
    M R van Schravendijk, W E Biddison, A E Berger and J E Coligan
    J Immunol January 1, 1985, 134 (1) 410-416;
  • You have accessRestricted access
    Demonstration of structural polymorphism among MB3 light chains by two-dimensional gel electrophoresis.
    N Ishikawa, M Kasahara, H Ikeda, K Ogasawara, S Hawkin, T Takenouchi, A Wakisaka, Y Kikuchi and M Aizawa
    J Immunol January 1, 1985, 134 (1) 417-422;
  • You have accessRestricted access
    Differential glycosylation requirements for the cell surface expression of class I molecules.
    N F Landolfi, R R Rich and R G Cook
    J Immunol January 1, 1985, 134 (1) 423-430;
  • You have accessRestricted access
    Interaction of monoclonal antibodies with MHC class I antigens on mouse spleen cells. II. Levels of expression of H-2K, H-2D, and H-2L in different mouse strains.
    S K Dower and D M Segal
    J Immunol January 1, 1985, 134 (1) 431-435;
  • You have accessRestricted access
    T15 D region germ line amino acid sequences distinguished by monoclonal anti-idiotope antibody.
    S Nishinarita, J L Claflin and R Lieberman
    J Immunol January 1, 1985, 134 (1) 436-442;
  • You have accessRestricted access
    The murine plasma cell antigen PC-1: purification and partial amino acid sequence.
    P A Stearne, I R van Driel, B Grego, R J Simpson and J W Goding
    J Immunol January 1, 1985, 134 (1) 443-448;
  • You have accessRestricted access
    Purification and distribution of a novel macrophage-specific calmodulin-binding glycoprotein.
    S J Orlow, D L Rosenstreich, S Pifko-Hirst and O M Rosen
    J Immunol January 1, 1985, 134 (1) 449-456;
  • You have accessRestricted access
    Identification of epitopes associated with hCG and the beta hCG carboxyl terminus by monoclonal antibodies produced against a synthetic peptide.
    J M Bidart, M Ozturk, D H Bellet, M Jolivet, H Gras-Masse, F Troalen, C J Bohuon and J R Wands
    J Immunol January 1, 1985, 134 (1) 457-464;
  • You have accessRestricted access
    Characterization of a polyvalent antibody directed against the IgG Fc receptor of human mononuclear phagocytes.
    C L Anderson, J M Spence, T S Edwards and J Nusbacher
    J Immunol January 1, 1985, 134 (1) 465-470;
  • You have accessRestricted access
    A linkage between the hemostatic and immune systems embodied in the fibrinolytic release of lymphocyte suppressive peptides.
    T S Edgington, L K Curtiss and E F Plow
    J Immunol January 1, 1985, 134 (1) 471-477;
  • You have accessRestricted access
    Quantitative measurements of the specificity and kinetics of conjugate formation between cloned cytotoxic T lymphocytes and splenic target cells by dual parameter flow cytometry.
    P Perez, J A Bluestone, D A Stephany and D M Segal
    J Immunol January 1, 1985, 134 (1) 478-485;
  • You have accessRestricted access
    Activation of the human classical complement pathway by a mouse monoclonal hybrid IgG1-2a monovalent anti-TNP antibody bound to TNP-conjugated cells.
    J Couderc, M D Kazatchkine, M Ventura, H T Duc, F Maillet, N Thobie and P Liacopoulos
    J Immunol January 1, 1985, 134 (1) 486-491;
  • You have accessRestricted access
    Binding and activation of hemolytic complement by IgG antibodies: cooperativity between antibodies of different hapten specificity.
    T Borsos and A Circolo
    J Immunol January 1, 1985, 134 (1) 492-494;
  • You have accessRestricted access
    The membrane attack complex of complement: C5b-8 complex as accelerator of C9 polymerization.
    J Tschopp, E R Podack and H J Müller-Eberhard
    J Immunol January 1, 1985, 134 (1) 495-499;
  • You have accessRestricted access
    Resistance to phagocytosis by group A streptococci: failure of deposited complement opsonins to interact with cellular receptors.
    J J Weis, S K Law, R P Levine and P P Cleary
    J Immunol January 1, 1985, 134 (1) 500-505;
  • You have accessRestricted access
    Enhanced reactive lysis of paroxysmal nocturnal hemoglobinuria erythrocytes by C5b-9 does not involve increased C7 binding or cell-bound C3b.
    S I Rosenfeld, D E Jenkins Jr and J P Leddy
    J Immunol January 1, 1985, 134 (1) 506-511;
  • You have accessRestricted access
    Normal function of CR1 on affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria.
    W N Roberts, J G Wilson, W Wong, D E Jenkins Jr, D T Fearon, K F Austen and A Nicholson-Weller
    J Immunol January 1, 1985, 134 (1) 512-517;
  • You have accessRestricted access
    The murine lymphocyte receptor for IgE. III. Use of chemical cross-linking reagents to further characterize the B lymphocyte Fc epsilon receptor.
    W T Lee and D H Conrad
    J Immunol January 1, 1985, 134 (1) 518-525;
  • You have accessRestricted access
    Monoclonal antibodies against human mast cell tryptase demonstrate shared antigenic sites on subunits of tryptase and selective localization of the enzyme to mast cells.
    L B Schwartz
    J Immunol January 1, 1985, 134 (1) 526-531;
  • You have accessRestricted access
    Morphologic and immunologic characterization of human basophils developed in cultures of cord blood mononuclear cells.
    T Ishizaka, A M Dvorak, D H Conrad, J R Niebyl, J P Marquette and K Ishizaka
    J Immunol January 1, 1985, 134 (1) 532-540;
  • You have accessRestricted access
    Complement- and IgE-mediated release of histamine from basophils in vitro. V. Differential effects of drugs modulating arachidonic acid metabolism.
    J Farnam, J A Grant, M A Lett-Brown, C Hunt, D O Thueson and P C Giclas
    J Immunol January 1, 1985, 134 (1) 541-547;
  • You have accessRestricted access
    Characterization of the effects of phorbol esters on rat mast cell secretion.
    A S Heiman and F T Crews
    J Immunol January 1, 1985, 134 (1) 548-555;
  • You have accessRestricted access
    Arachidonic acid metabolism by murine peritoneal macrophages infected with Leishmania donovani: in vitro evidence for parasite-induced alterations in cyclooxygenase and lipoxygenase pathways.
    N E Reiner and C J Malemud
    J Immunol January 1, 1985, 134 (1) 556-563;
  • You have accessRestricted access
    Nerve growth factor: a chemotactic factor for polymorphonuclear leukocytes in vivo.
    M D Boyle, M J Lawman, A P Gee and M Young
    J Immunol January 1, 1985, 134 (1) 564-568;
  • You have accessRestricted access
    H-2K-restricted granuloma formation by Ly-2+ T cells in antibacterial protection to facultative intracellular bacteria.
    H Näher, U Sperling and H Hahn
    J Immunol January 1, 1985, 134 (1) 569-572;
  • You have accessRestricted access
    A novel IgA protease from Clostridium sp. capable of cleaving IgA1 and IgA2 A2m(1) but not IgA2 A2m(2) allotype paraproteins.
    Y Fujiyama, K Kobayashi, S Senda, Y Benno, T Bamba and S Hosoda
    J Immunol January 1, 1985, 134 (1) 573-576;
  • You have accessRestricted access
    Regulation of cell-mediated immunity in cryptococcosis. III. Characterization of second-order T suppressor cells (Ts2).
    J W Murphy and R L Mosley
    J Immunol January 1, 1985, 134 (1) 577-584;
  • You have accessRestricted access
    Characterization of monoclonal antibodies to Treponema pallidum.
    S A Lukehart, M R Tam, J Hom, S A Baker-Zander, K K Holmes and R C Nowinski
    J Immunol January 1, 1985, 134 (1) 585-592;
  • You have accessRestricted access
    Identification of an antigen specific to Trypanosoma congolense by using monoclonal antibodies.
    N M Parish, W I Morrison and T W Pearson
    J Immunol January 1, 1985, 134 (1) 593-597;
  • You have accessRestricted access
    Natural killer cells vs cytotoxic T cells in the peripheral blood of virus-infected mice.
    L Stitz, A Althage, H Hengartner and R Zinkernagel
    J Immunol January 1, 1985, 134 (1) 598-602;
  • You have accessRestricted access
    B cell subsets in spleens of BALB/c mice: identification and isolation of MMTV-expressing and MMTV-responding subpopulations.
    D M Lopez, V Charyulu and R D Paul
    J Immunol January 1, 1985, 134 (1) 603-607;
  • You have accessRestricted access
    Mechanism of recovery from acute virus infection. I. Role of T lymphocytes in the clearance of lymphocytic choriomeningitis virus from spleens of mice.
    F Lehmann-Grube, U Assmann, C Löliger, D Moskophidis and J Löhler
    J Immunol January 1, 1985, 134 (1) 608-615;
  • You have accessRestricted access
    Recognition of influenza virus hemagglutinin by subtype-specific and cross-reactive proliferative T cells: contribution of HA1 and HA2 polypeptide chains.
    J M Katz, W G Laver, D O White and E M Anders
    J Immunol January 1, 1985, 134 (1) 616-622;
  • You have accessRestricted access
    In vitro mutagenesis of a mouse MHC class I gene for the examination of structure-function relationships.
    T Shiroishi, G A Evans, E Appella and K Ozato
    J Immunol January 1, 1985, 134 (1) 623-629;
  • You have accessRestricted access
    Comparison of MHC genes among distantly related members of the genus Mus.
    M J Rogers, R N Germain, J Hare, E Long and D S Singer
    J Immunol January 1, 1985, 134 (1) 630-636;
  • You have accessRestricted access
    Transcriptional regulation of HLA class II and invariant chain genes.
    F Levine, H A Erlich, B Mach and D Pious
    J Immunol January 1, 1985, 134 (1) 637-640;
  • You have accessRestricted access
    Localization of the human MHC-linked complement genes between HLA-B and HLA-DR by using HLA mutant cell lines.
    A S Whitehead, H R Colten, C C Chang and R Demars
    J Immunol January 1, 1985, 134 (1) 641-643;
  • You have accessRestricted access
    T cells with FC receptors in myeloma; suppression of growth and secretion of MOPC-315 by T alpha cells.
    S Müller and R G Hoover
    J Immunol January 1, 1985, 134 (1) 644-647;
  • You have accessRestricted access
    Functional analysis of mononuclear cells infiltrating into tumors: differential cytotoxicity of mononuclear cells from tumors of immune and nonimmune rats.
    Y Ibayashi, T Uede, T Uede and K Kikuchi
    J Immunol January 1, 1985, 134 (1) 648-653;
  • You have accessRestricted access
    Obituary: Manfred Martin Mayer June 15, 1916-September 18, 1984.
    E A Kabat
    J Immunol January 1, 1985, 134 (1) 654-656;

ANNOUNCEMENTS

  • You have accessRestricted access
    Nomenclature
    listed no author
    J Immunol January 1, 1985, 134 (1) 659-660;
Back to top
PreviousNext
PreviousNext

This Issue

The Journal of Immunology
Vol. 134, Issue 1
1 Jan 1985
  • Table of Contents
  • Table of Contents (PDF)
Sign up for alerts

Jump to

  • ANNOUNCEMENTS
  • Highlights
  • Most Cited
  • Most Read
Loading
Immunodominant AH1 Antigen-Deficient Necroptotic, but Not Apoptotic, Murine Cancer Cells Induce Antitumor Protection
Osteoclasts Derive Predominantly from Bone Marrow–Resident CX3CR1+ Precursor Cells in Homeostasis, whereas Circulating CX3CR1+ Cells Contribute to Osteoclast Development during Fracture Repair
Intracellular IL-1 Receptor Antagonist Isoform 1 Released from Keratinocytes upon Cell Death Acts as an Inhibitor for the Alarmin IL-1α
Polysaccharide Capsules Equip the Human Symbiont Bacteroides thetaiotaomicron to Modulate Immune Responses to a Dominant Antigen in the Intestine
Natural and Induced Tolerogenic Dendritic Cells
Cutting Edge: IL-6–Driven Immune Dysregulation Is Strictly Dependent on IL-6R α-Chain Expression

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • FAR 889
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2022 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606